6-43046560-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_014780.5(CUL7):​c.2439A>G​(p.Gln813Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.972 in 1,614,046 control chromosomes in the GnomAD database, including 762,366 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.98 ( 73000 hom., cov: 31)
Exomes 𝑓: 0.97 ( 689366 hom. )

Consequence

CUL7
NM_014780.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.505

Publications

16 publications found
Variant links:
Genes affected
CUL7 (HGNC:21024): (cullin 7) The protein encoded by this gene is a component of an E3 ubiquitin-protein ligase complex. The encoded protein interacts with TP53, CUL9, and FBXW8 proteins. Defects in this gene are a cause of 3M syndrome type 1 (3M1). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
KLC4 (HGNC:21624): (kinesin light chain 4) Predicted to be located in cytoplasm and microtubule. Predicted to be part of kinesin complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 6-43046560-T-C is Benign according to our data. Variant chr6-43046560-T-C is described in ClinVar as Benign. ClinVar VariationId is 260437.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.505 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.986 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CUL7NM_014780.5 linkc.2439A>G p.Gln813Gln synonymous_variant Exon 11 of 26 ENST00000265348.9 NP_055595.2 Q14999-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CUL7ENST00000265348.9 linkc.2439A>G p.Gln813Gln synonymous_variant Exon 11 of 26 1 NM_014780.5 ENSP00000265348.4 Q14999-1

Frequencies

GnomAD3 genomes
AF:
0.979
AC:
148920
AN:
152106
Hom.:
72938
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.994
Gnomad AMI
AF:
0.993
Gnomad AMR
AF:
0.982
Gnomad ASJ
AF:
0.895
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
0.988
Gnomad FIN
AF:
0.995
Gnomad MID
AF:
0.949
Gnomad NFE
AF:
0.969
Gnomad OTH
AF:
0.973
GnomAD2 exomes
AF:
0.976
AC:
245352
AN:
251320
AF XY:
0.975
show subpopulations
Gnomad AFR exome
AF:
0.995
Gnomad AMR exome
AF:
0.985
Gnomad ASJ exome
AF:
0.894
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.992
Gnomad NFE exome
AF:
0.968
Gnomad OTH exome
AF:
0.971
GnomAD4 exome
AF:
0.971
AC:
1419492
AN:
1461822
Hom.:
689366
Cov.:
119
AF XY:
0.971
AC XY:
706150
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.995
AC:
33321
AN:
33480
American (AMR)
AF:
0.983
AC:
43961
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.891
AC:
23285
AN:
26134
East Asian (EAS)
AF:
0.999
AC:
39675
AN:
39700
South Asian (SAS)
AF:
0.989
AC:
85349
AN:
86258
European-Finnish (FIN)
AF:
0.992
AC:
52966
AN:
53420
Middle Eastern (MID)
AF:
0.933
AC:
5384
AN:
5768
European-Non Finnish (NFE)
AF:
0.969
AC:
1076975
AN:
1111954
Other (OTH)
AF:
0.970
AC:
58576
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
2902
5805
8707
11610
14512
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21650
43300
64950
86600
108250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.979
AC:
149041
AN:
152224
Hom.:
73000
Cov.:
31
AF XY:
0.981
AC XY:
73031
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.994
AC:
41259
AN:
41514
American (AMR)
AF:
0.982
AC:
15008
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.895
AC:
3106
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5172
AN:
5174
South Asian (SAS)
AF:
0.988
AC:
4775
AN:
4832
European-Finnish (FIN)
AF:
0.995
AC:
10576
AN:
10626
Middle Eastern (MID)
AF:
0.949
AC:
277
AN:
292
European-Non Finnish (NFE)
AF:
0.969
AC:
65910
AN:
68006
Other (OTH)
AF:
0.973
AC:
2052
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
162
324
485
647
809
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.970
Hom.:
59471
Bravo
AF:
0.978
Asia WGS
AF:
0.992
AC:
3449
AN:
3478
EpiCase
AF:
0.969
EpiControl
AF:
0.964

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

3M syndrome 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
5.7
DANN
Benign
0.72
PhyloP100
0.51
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9394939; hg19: chr6-43014298; COSMIC: COSV99538180; API